Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
US12122844B2 · kind B2 · utility
2Cited by
12References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 13, 2020 |
| Grant date | Oct 22, 2024 |
| Priority date | — |
| Expiry date | Nov 19, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/025
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods to inhibit or treat brain cancers by locally inhibiting expression or activity of growth factors or growth factor receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.